Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

@article{Collett2010ComparisonOT,
  title={Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit},
  author={Dave Collett and Lisa L Mumford and Nicholas Robert Banner and James Neuberger and Christopher J. E. Watson},
  journal={American Journal of Transplantation},
  year={2010},
  volume={10}
}
An increased incidence of malignancy is an established complication of organ transplantation and the associated immunosuppression. In this study on cancer incidence in solid organ transplant recipients in Britain, we describe the incidence of de novo cancers in the allograft recipient, and compare these incidences following the transplantation of different organs. Data in the UK Transplant Registry held by NHS Blood and Transplant (NHSBT) were linked with data made available by the cancer… 
Malignancy after Heart Transplantation: A Systematic Review of the Incidence and Risk Factors Compared with Other Solid Organ Transplants
TLDR
Transplant physicians should probably increase the threshold of attention for cancer risk surveillance in addition to anti-rejection therapy for graft survivals, as it seems that the incidence of cancer risk is probably higher in HT than SOT recipients.
De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study
TLDR
A three-fold increase in de noVO cancer risk in organ transplant patients compared with the general population is revealed and illustrated the importance of de novo malignancy after organ transplantation.
Thirty-seven-year Population-based Study of Colorectal Cancer Rates in Renal Transplant Recipients in Ireland.
TLDR
The data suggest that Irish transplant recipients have an increased risk of being diagnosed with a more advanced tumor than the general population, with most being diagnosed almost a decade after transplantation.
Malignancies After Kidney Transplantation: Hong Kong Renal Registry
  • C. Cheung, M. Lam, +9 authors K. Chau
  • Medicine
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2012
TLDR
Patterns of cancer incidence and mortality in kidney transplant recipients were compared with those of the general population using standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) respectively.
Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single center.
TLDR
This study demonstrated distinctive cumulative incidences of dM in different clinical and pathologic settings, reaching a substantially higher incidence than that of lymphoid dM beyond 5 years after SOT.
De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data
TLDR
Strategies of cancer prevention and screening after kidney and liver transplantation should be developed in response to the incidence of common types of de novo cancers.
A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.
  • R. Higgins, Robert N. Brown, +5 authors J. George
  • Medicine
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2014
TLDR
The risk of malignancy has markedly declined during a 15-year period such that the aggregate rate ofmalignancy approached that of the general population in the United States.
Organ transplantation related cancer
TLDR
A comparison of the organ donor data with the guidelines classifying the donor’s risk showed that a selected cohort of donors could safely donate their organs resulting in valuable additional survival for the recipients, with low risk of cancer transmission.
Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients
TLDR
Understanding the factors responsible for the higher cancer incidence in cardiothoracic compared to liver recipients has the potential to lead to targeted cancer prevention strategies in this high‐risk population.
Incidence and Mortality by Cancer in Patients After Lung Transplantation in a Brazilian Institution.
TLDR
The incidence of malignancies was higher in lung-transplanted patients of a Brazilian institution in comparison with the Brazilian population, and the most frequent types of cancer are in accordance with the literature, except for prostate cancer.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Cancer Incidence Among Canadian Kidney Transplant Recipients
TLDR
This study confirms previous findings of increased risks of posttransplant cancer and underscores the need for increased vigilance among kidney transplant recipients for cancers at sites where there are no population‐based screening programs in place.
Cancer incidence in a kidney-transplanted population
TLDR
The increased incidence of cancer in the transplant population is shown and the importance of cancer surveillance in the years following kidney transplantation is pointed out.
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
TLDR
Results show that HIV-infected individuals and transplant recipients share a similar pattern of cancer risk, largely due to virus-related cancers.
Cancer risk after renal transplantation in Japan
TLDR
The findings showed the excess risk of malignancies in Japan with renal transplants, especially in male patients, similar to that observed in Western countries, though the types ofmalignancy were different.
Cancer risk following organ transplantation: a nationwide cohort study in Sweden
TLDR
In conclusion, organ transplantation entails a persistent, about four-fold increased overall cancer risk, and the complex pattern of excess risk at many sites challenges current understanding of oncogenic infections that might become activated by immunologic alterations.
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation
TLDR
The incidence of de-novo breast cancer arising in women receiving immunosuppressive therapy after kidney or heart transplantation is examined, and observations raise the possibility of therapeutic manipulation of specific immune mechanisms that promote tumour growth.
Risk of renal cell carcinoma after kidney transplantation.
TLDR
The main risk factors for the development of renal cell carcinoma seem to be so-called acquired cystic disease of the native kidneys and the underlying renal disease, such as analgesic nephropathy, and obviously not the immunosuppressive regimen after transplantation.
Incidence and risk factors for cancer after liver transplantation.
TLDR
Some risk factors, such as age, smoking, alcohol and others seem to play a role in higher risk for malignancy, but the presence of a long-term immunosuppressive state, more than the specific regimen used, is the basis for this higher incidence.
Cancer screening in renal transplant recipients: what is the evidence?
TLDR
Critically appraised guidelines for cancer screening in the renal transplant and general populations using standard criteria for an evidence-based screening program, finding validity of their recommendations are uncertain.
Post-transplantation malignant disease in patients with analgesic nephropathy
TLDR
In the authors' department 12 out of 320 renal transplant recipients had analgesic nephropathy, with anusually high risk of malignancy after transplantation.
...
1
2
3
...